Showing results (11-20 of 133) with videos related to
Sort By:
Pageof 14
Clinical Case Reports|September 5, 2020
A case of metachronous peripheral T-Cell non-Hodgkin lymphoma following chemotherapy for Hodgkin disease successfully treated with brentuximab vedotinFederico Meconi, Ida Provenzano, Daniela Nasso, et al.Transfusion|June 25, 2013
A new system for quality control in hematopoietic progenitor cell units before reinfusion in autologous transplantMaria Cristina Scerpa, Cecilia Rossi, Nicola Daniele, et al.Current Opinion in Oncology|August 12, 2009
Monitoring of minimal residual disease in acute myeloid leukemiaFrancesco Buccisano, Luca Maurillo, Alessandra Spagnoli, et al.Journal of Medical Virology|July 24, 2009
Excretion of the novel polyomaviruses KI and WU in the stool of patients with hematological disordersMuhammed Babakir-Mina, Massimo Ciccozzi, Claudia Alteri, et al.Blood|November 1, 2011
Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemiaFrancesco Buccisano, Luca Maurillo, Maria Ilaria Del Principe, et al.Transfusion|October 14, 2009
Platelet gel for treatment of mucocutaneous lesions related to graft-versus-host disease after allogeneic hematopoietic stem cell transplantAlessandra Picardi, Alessandro Lanti, Laura Cudillo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2002
Relevance of bone marrow cell dose on allogeneic transplantation outcomes for patients with acute myeloid leukemia in first complete remission: results of a European surveyVanderson Rocha, Myriam Labopin, Eliane Gluckman, et al.Transfusion|October 29, 2008
Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood, and haploidentical hematopoietic stem cell transplantationMaria Cristina Tirindelli, Gerardo Flammia, Federico Sergi, et al.American Journal of Hematology|April 13, 2018
Optimizing the pretransplant regimen for autologous stem cell transplantation in acute myelogenous leukemia: Better outcomes with busulfan and melphalan compared with busulfan and cyclophosphamide in high risk patients autografted in first complete remission: A study from the acute leukemia working party of the EBMTNorbert Claude Gorin, Myriam Labopin, Didier Blaise, et al.Mediterranean Journal of Hematology and Infectious Diseases|May 26, 2022
The Venetoclax/Azacitidine Combination Targets the Disease Clone in Acute Myeloid Leukemia, Being Effective and Safe in a Patient with COVID-19Antonio Cristiano, Raffaele Palmieri, Emiliano Fabiani, et al.Pageof 14